Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-16

Clinical Trial Update: Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa

View source ↗

Summary

Ongoing clinical trial evaluating the efficacy and safety of secukinumab in conjunction with surgery for moderate-to-severe hidradenitis suppurativa; recruitmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Secukinumab (secukinumab)

Snippet

Sponsor: Peking Union Medical College | Conditions: Hidradenitis Suppurativa (HS), Hidradenitis Suppurativa (Acne Inversa) | Status: RECRUITING